Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBRUTINIB vs IBUPROFEN LYSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBRUTINIB vs IBUPROFEN LYSINE: Safety Overview

Metric IBRUTINIB IBUPROFEN LYSINE
Total FAERS Reports 75,087 277
Deaths Reported 12,580 27
Death Rate 16.8% 9.7%
Hospitalizations 24,920 110
Average Patient Age 71.2 yrs 12.6 yrs
% Female Patients 39.2% 46.1%
FDA Approval Date Aug 24, 2022 Apr 13, 2006
Manufacturer Pharmacyclics LLC Recordati Rare Diseases Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription